S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 GenprexLipocineImmunomeLiminal BioSciencesSynlogic
SymbolNASDAQ:GNPXNASDAQ:LPCNNASDAQ:IMNMNASDAQ:LMNLNASDAQ:SYBX
Price Information
Current Price$4.90$1.43$29.84$4.20$3.41
52 Week RangeBuyBuyBuyHoldBuy
MarketRank™
Overall Score1.01.41.11.11.6
Analysis Score2.53.51.53.13.3
Community Score2.42.83.31.92.7
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.8
Earnings & Valuation Score0.00.60.60.61.3
Analyst Ratings
Consensus RecommendationBuyBuyBuyHoldBuy
Consensus Price Target$6.00$3.00$18.00$18.00$11.50
% Upside from Price Target22.45% upside109.79% upside-39.68% downside328.56% upside237.24% upside
Trade Information
Market Cap$212.06 million$117.42 million$314.57 million$123.42 million$118.78 million
Beta-0.570.75N/A1.872.2
Average Volume1,773,6975,290,965386,4601,243,2751,391,597
Sales & Book Value
Annual RevenueN/A$170,000.00N/A$3.70 million$2.22 million
Price / SalesN/A690.73N/A33.3653.51
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.15 per share$0.25 per shareN/A$3.06 per share$4.86 per share
Price / BookN/A5.72N/A1.370.70
Profitability
Net Income$-10,650,000.00$-13,010,000.00$-10,440,000.00$-155,020,000.00$-51,370,000.00
EPS($0.67)($0.50)N/A($10.94)($1.70)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-2,758.32%-2,761.83%
Return on Equity (ROE)-81.49%-195.34%N/A-196.39%-41.64%
Return on Assets (ROA)-79.54%-88.86%N/A-88.62%-34.39%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.22%N/A2.42%N/A
Current Ratio60.40%4.27%1.38%2.17%16.42%
Quick Ratio58.58%4.27%1.38%1.75%16.42%
Ownership Information
Institutional Ownership Percentage12.50%10.87%N/A13.45%39.53%
Insider Ownership Percentage13.05%10.50%N/AN/A17.95%
Miscellaneous
Employees8122130076
Shares Outstanding43.28 million82.12 million10.54 million29.39 million34.83 million
Next Earnings Date3/29/2021 (Estimated)3/12/2021 (Estimated)3/9/2021 (Estimated)3/19/2021 (Estimated)3/11/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.